Summary
The trial showed that heart attacks, strokes, and other serious events did not decrease.
Researchers will analyze the detailed results to decide the next steps for heart‑health medicines.
The drug successfully lowered lipoprotein a levels.
The study did not meet its main goal of cutting heart attacks and strokes.
Other companies are developing different medicines that also target lipoprotein a.
Doctors already use lipoprotein a tests to assess inherited heart risk.
The trial showed that heart attacks, strokes, and other serious events did not decrease.
Researchers will analyze the detailed results to decide the next steps for heart‑health medicines.
Want to learn even more? Click here to read the full story!